Public Policy Priorities

Advocating for a Greater Life Science Future

 
Agricultural and Industrial Biotech
Agricultural and Industrial Biotech

Biotechnology has revolutionized how we feed and fuel the world and is a driver of some of the most exciting advancements in agriculture and energy of the century. By supporting policies that promote the development and production of advanced biofuels, renewable chemicals and biobased products, and communicate science-based information to consumers relevant to health, safety, and nutrition, Biocom gives members a powerful voice in Washington, D.C. and an environment which supports agricultural and industrial biotechnology innovation.Learn More

Biomedical Research Funding
Biomedical Research Funding

Federal investment in biomedical research is essential to the development of new drugs, vaccines, and technologies by supporting breakthrough research happening across the nation and especially in California. In Fiscal Year 2016, funding from the National Institutes of Health (NIH) supported over 7,500 grants in California alone, helping universities, research institutes and small companies turn ideas into innovative products. Biocom’s policy team is relentless working to ensure the continuity of funding for the NIH as well as biodefense and pandemic research programs. Learn More

Climate
Climate

Government standards for greenhouse gas emissions reduction came from state legislation Assembly Bill 32, passed in 2006 under Governor Schwarzenegger. AB 32’s basic goal was for California to reduce greenhouse gas emissions to 1990 levels by 2020. Ensuing state legislation has codified a 2030 greenhouse gas emissions reduction target of 40% below 1990 levels.

A major vehicle for reaching these targets are local Climate Action Plans. Biocom works with regional governments to give input on climate policies and Climate Action Plan implementation.

Additionally, Biocom assists our members with achieving their sustainability goals by connecting them with government and consultant resources, sharing best practices at events and through our Facilities/EH&S committees, and showcasing member companies that are implementing sustainable practices. Learn More

Digital Health and Genomics
Digital Health and Genomics

Digital health has revolutionized our health care system by introducing technologies that allow for more efficient, targeted, and patient-centered approaches to the diagnostic and treatment of disease and delivery of care. As a result, Biocom staunchly supports policies that streamline the regulation and expand the reimbursement of digital apps and devices, remote patient monitoring technologies, and genomics products, as well as educational efforts that help patients, providers, and caregivers better understand the benefits and usage of these life-changing products. Learn More

FDA Regulatory Policy
FDA Regulatory Policy

Biocom is dedicated to improving the drug and device review and approval process, communication between industry and the Food and Drug Administration (FDA), and transparency and accountability within the agency. From advocating for continued funding for the agency and supporting industry-friendly legislation, to engaging on important regulatory matters and keeping members up-to-date, Biocom works with Congress, the FDA, and industry to create an environment that helps bring new treatments and cures to patients faster. Learn More

Intellectual Property and Patent Law
Intellectual Property and Patent Law

Intellectual property is the lifeblood of the life science industry. Patents are so important to America’s prosperity that they have been enshrined in our Constitution as fundamental rights. Those rights have provided the foundation for a culture of innovation and entrepreneurship that has been an essential driver of our exceptional economic growth and global leadership. Biocom has vehemently opposed and will continue to oppose legislation that undermines those rights in any way, while supporting initiatives in Congress and at the Patent and Trademark Office (USPTO) that promote life science innovation. Learn More

Land Use and Transportation
Land Use and Transportation

In regional markets throughout California, land set aside for commercial use and/or Research and Development is scarce. Biocom advocates for protection of land for life science development, and assists our members with navigating development processes.

Additionally, we recognize that commuting and transportation can be challenging for employees in the busy San Diego, Los Angeles, and San Francisco Bay Area regions. Biocom supports transportation infrastructure that offers a variety of options for transporting goods, and for getting to/from work. Learn More

Reimbursement and Patient Access To Care
Reimbursement and Patient Access To Care

Biocom is committed to ensuring that patients have access to the care they need and supports reimbursement policies that provide appropriate and inclusive coverage, coding, and payment for biopharmaceutical, medical device, diagnostic, and genomics products. Biocom has strongly opposed proposals that would cut reimbursement to physicians under Medicare Part B, impose rebates and price controls to Medicare Part D, and limit the availability of products through restrictive formularies, step therapy, and increased cost-sharing such as specialty tiers and high deductibles. Learn More

STEM Education and Workforce
STEM Education and Workforce

Biocom supports science, technology, engineering, and math (STEM) education in the United States to inspire the industry leaders of tomorrow and equip educators with the tools needed to prepare them. Through the Biocom Institute and dozens of annual programs, Biocom promotes the life sciences by creating opportunities for STEM students, teachers, scientists, and life science companies to work together and grow a diverse community of life science professionals. Biocom also supports immigration policies that provide American employers with greater access to the world’s best talents. Learn More

Taxes
Taxes

Biocom is advocating for tax policies that promote research, innovation, and advanced manufacturing. A lower corporate tax code, territorial tax system, and incentives for high-risk industries would ensure that U.S. companies are successful at home and competitive abroad.

Biocom also supports keeping the research and development tax credit permanent, repealing the medical device tax, and extending the orphan drug tax credit and renewable energy tax incentives.

At the local level, the implementation of additional city taxes and fees can have detrimental effects on the development and production of new treatments. Biocom works with elected officials to educate them on the effects of new proposals on the life science industry, and we are often involved in achieving compromises that mitigate tax and fee impacts on our members. Learn More

Water
Water

Biocom was founded in 1995 to educate elected officials about water needs of the life science industry. Today, we continue to advocate for a reliable, accessible water supply for our members, who depend on a constant source of water for everyday business. Interrupting these supplies could mean millions of dollars lost in delicate research.

Biocom has also supported a number of practical ways to diversify water supply, such as indirect potable reuse and desalination, and has worked closely with local and state water officials to ensure consideration for the industry in new and existing regulations. Learn More

 

Federal and Regional Policy Priorities

 
Federal Policy Priorities
Federal Policy Priorities

Biocom's Federal Policy Priorities include Biomedical Research Funding, FDA Regulatory Policy, Taxes, and Digital Health and Genomics.

Learn More

San Diego Regional Policy Priorities
San Diego Regional Policy Priorities

Biocom's San Diego Regional Policy Priorities include Access to Water, Climate Action Plan, Prime Industrial Land, and SANDAG 2050 Regional Plan.

Learn More

Los Angeles Regional Policy Priorities
Los Angeles Regional Policy Priorities

Biocom's Los Angeles Regional Policy Priorities include Linkage Fee, Gross Receipts Tax, Workforce Development and Propel LA.

Learn More

 

Public Policy Newsletter

Members: Sign up to receive updates regarding the most important recent policy news.